At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital Universitari Vall d’Hebron, Barcelona, Spain, explains that high response rates observed with neoadjuvant treatment in patients with breast cancer is enabling a trend towards breast conservative surgery.
Allergy & Immunology
